The Bayer NEJM paper points out several respects in which attention to public health efforts is stagnating. Which agencies or types of academic/government/nonprofit positions can best reinvigorate the conversation about the need for public health advances in today's genetic data-driven era>
Sandro Galea, MD, MPH, DrPH
Dean and Professor at Boston University School of Public Health
Mary Carol Jennings, MD, MPH
Public Health Physician
Medical Student at University of Pittsburgh School of Medicine
- All Questions & Answers
- Question: Day 7: Which people/agencies are poised to be the best spokespersons for...